PathMaker will be presenting at the 11th Annual Neurotech Investing and Partnering Conference being held April 6-7 in Boston Boston, MA and Manhasset, NY – PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders, announced today that it has launched an Institutional Review Board (IRB)-approved… read more